The Latest in Gene Therapy Research
Medical Innovations
129 views
Medical Innovations
129 views

The Latest in Gene Therapy Research

Eileen O'Brien - May 10, 2013

Gene therapy was the topic at the Healthcare Businesswomen’s Association event on April 30 with Ricki Lewis, PhD. The crowd was captivated as Dr. Gene therapy was…

Highlights from the World Orphan Drug Congress 2013
Specialties
155 views
Specialties
155 views

Highlights from the World Orphan Drug Congress 2013

Eileen O'Brien - April 24, 2013

A key theme of the World Orphan Drug Congress 2013 was the need to innovate when it comes to the rare disease space. Presenters shared how rare…

Mobile Health
124 views

The Importance of Patient Advocates for Orphan Drugs

Eileen O'Brien - April 19, 2013

I attended the World Orphan Drug Congress last week in Washington, DC, and Siren presented the workshop, “A Roadmap for Patient Advocacy Investment.” In the rare disease…

A Chat With Rare Disease Advocate Ed Fennell
Specialties
129 views
Specialties
129 views

A Chat With Rare Disease Advocate Ed Fennell

Eileen O'Brien - April 4, 2013

Last week I had a fascinating phone conversation with rare disease advocate, Ed Fennell. Full of energy, he is helping to care for 2 young granddaughters –…

FDA’s Dr. Katz Talks Social Media and Clinical Trials
Business
257 views
Business
257 views

FDA’s Dr. Katz Talks Social Media and Clinical Trials

Eileen O'Brien - March 27, 2013

I was fortunate to be invited to speak at the American Society for Experimental NeuroTherapeutics (ASENT) annual meeting on February 28, 2013 in Bethedsa, MD. I was…

FindZebra: Rare Disease Search Engine
Diagnostics
176 views
Diagnostics
176 views

FindZebra: Rare Disease Search Engine

Eileen O'Brien - March 23, 2013

Physicians are trained to arrive at a medical diagnosis by starting with the potential causes that are most common. Physicians are trained to arrive at a medical…

Does FTC Social Media Guidance Provide Clues for Pharma?
Policy & Law
182 views
Policy & Law
182 views

Does FTC Social Media Guidance Provide Clues for Pharma?

Eileen O'Brien - March 15, 2013

The pharmaceutical industry has yet to receive specific guidance from the U.S. Food and Drug Administration (FDA) on social media. People are wondering if the Federal Trade…

FDA Warning Letter: Don’t Make Unsubstantiated Claims, Even on Facebook
Policy & Law
166 views
Policy & Law
166 views

FDA Warning Letter: Don’t Make Unsubstantiated Claims, Even on Facebook

Eileen O'Brien - March 7, 2013

In December 2012, the FDA sent a warning letter to Amarc Enterprises regarding two websites. In December 2012, the FDA sent a warning letter to Amarc Enterprises…

FDA Letter Mentions Internal Site Search
eHealth
141 views
eHealth
141 views

FDA Letter Mentions Internal Site Search

Eileen O'Brien - February 22, 2013

We recently reviewed this FDA warning letter sent on January 29, 2013 to Medical Doctors Research (MDR), a nutritional supplement manufacturer. We recently reviewed this FDA warning…

The Importance of Content Marketing For Orphan Drugs
Business
110 views
Business
110 views

The Importance of Content Marketing For Orphan Drugs

Eileen O'Brien - February 19, 2013

Content marketing is currently a hot trend, but in the rare disease space it’s been an essential tactic for years. Content marketing is currently a hot trend,…